Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-(3-((3aS,4R,7S,9R,10R,11S,13R,15R,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-7-fluoro-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxododecahydro-2H-[1]oxacyclotetradecino[4,3-d]oxazol-1(4H)-yl)propyl)-N-(quinolin-3-yl)benzamide
ID: ALA5277474
Chembl Id: CHEMBL5277474
Max Phase: Preclinical
Molecular Formula: C50H67FN4O11
Molecular Weight: 919.10
Associated Items: